InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by Bolzon Bradley J PhD, Director. Director active across 2 companies, notably CRISPR Therapeutics AG. In total, 10 filings have been logged. Total volume traded: €2.7m. The latest transaction was filed on 19 July 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€373,3693,504 shares@ €106.55527.9% of flow
Common Shares
SEC:0000899243-21-029271·
€373,3693,504 shares@ €106.5550.0080% mcap13.9% of flow
Common Shares
SEC:0000899243-21-029271:0·
6,515,869 shares
Common Stock
SEC:0000899243-21-026769·
€406,1493,216 shares@ €126.290130.3% of flow
Common Shares
SEC:0000899243-21-026800·
0615,607 shares0
Common Shares
SEC:0000899243-21-026801·
6,515,869 shares
Common Stock
SEC:0000899243-21-026769:0·
€406,1493,216 shares@ €126.29010.0087% mcap15.2% of flow
Common Shares
SEC:0000899243-21-026800:0·
0615,607 shares0
Common Shares
SEC:0000899243-21-026801:0·
€560,0745,427 shares@ €103.201441.8% of flow
Common Shares
SEC:0000899243-21-023880·
€560,0745,427 shares@ €103.20140.012% mcap20.9% of flow
Common Shares
SEC:0000899243-21-023880:0·
10 of 10 declarations
About Bolzon Bradley J PhD
Bradley J. Bolzon, PhD, serves as a Director at CRISPR Therapeutics AG and Monte Rosa Therapeutics, Inc. He plays a key role in the governance of these companies and in shaping their strategy. His expertise in biotechnology is an asset to the board.
